This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
n11http://linked.opendata.cz/resource/drugbank/drug/DB07203/identifier/pubchem-compound/
dctermshttp://purl.org/dc/terms/
n8http://linked.opendata.cz/resource/drugbank/drug/DB07203/identifier/pubchem-substance/
n13http://linked.opendata.cz/resource/drugbank/drug/DB07203/identifier/drugbank/
n6http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n12http://linked.opendata.cz/resource/drugbank/drug/DB07203/identifier/chemspider/
n14http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n9http://linked.opendata.cz/resource/drugbank/drug/DB07203/identifier/pdb/

Statements

Subject Item
n2:DB07203
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n6:DB07203 n14:DB07203
dcterms:title
6-CYCLOHEXYLMETHOXY-2-(3'-CHLOROANILINO) PURINE
adms:identifier
n8:99443674 n9:6CP n11:4565 n12:4405 n13:DB07203
n3:IUPAC-Name
n4:271B5424-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B542A-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B5429-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B5426-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B5427-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B5428-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B5422-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B5420-363D-11E5-9242-09173F13E4C5 n4:271B5423-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B5421-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B5430-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B5431-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B542B-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B542C-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B542E-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B542D-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B542F-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B5436-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B5438-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B5439-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B5435-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B5434-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B5437-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B5425-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B5432-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B5433-363D-11E5-9242-09173F13E4C5